beta, beta-dimethylacrylshikonin has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, H; Zhang, G | 1 |
| Ma, XQ; Wang, HB | 1 |
2 other study(ies) available for beta, beta-dimethylacrylshikonin and Adenocarcinoma
| Article | Year |
|---|---|
Endoplasmic reticulum stress-mediated autophagy protects against β,β-dimethylacrylshikonin-induced apoptosis in lung adenocarcinoma cells.
Topics: A549 Cells; Adenocarcinoma; Apoptosis; Autophagy; Autophagy-Related Protein 5; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum Stress; Humans; Lung Neoplasms; Naphthoquinones; RNA Interference; Signal Transduction; Transcription Factor CHOP; Unfolded Protein Response | 2018 |
β, β-Dimethylacrylshikonin induces mitochondria-dependent apoptosis of human lung adenocarcinoma cells in vitro via p38 pathway activation.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mitochondria; Naphthoquinones; Signal Transduction | 2015 |